US FDA News: FDA and NIH Launch Public-Private Partnership for Rare Neurodegenerative Diseases

FDA and NIH launch Critical Path for Rare Neurodegenerative Diseases – a public-private partnership aimed at advancing the understanding of rare neurodegenerative diseases and fostering the development of treatments.
Read more: FDA and NIH Launch Public-Private Partnership for Rare Neurodegenerative Diseases